DK3442657T3 - Fremgangsmåde til evaluering af artikulære ledterapi - Google Patents

Fremgangsmåde til evaluering af artikulære ledterapi Download PDF

Info

Publication number
DK3442657T3
DK3442657T3 DK16898834.3T DK16898834T DK3442657T3 DK 3442657 T3 DK3442657 T3 DK 3442657T3 DK 16898834 T DK16898834 T DK 16898834T DK 3442657 T3 DK3442657 T3 DK 3442657T3
Authority
DK
Denmark
Prior art keywords
evaluation
procedure
articular joint
joint therapy
therapy
Prior art date
Application number
DK16898834.3T
Other languages
English (en)
Inventor
Kevin J Ruff
Original Assignee
Esm Tech Llc
Kevin J Ruff
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esm Tech Llc, Kevin J Ruff filed Critical Esm Tech Llc
Application granted granted Critical
Publication of DK3442657T3 publication Critical patent/DK3442657T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082Supracellular entities, e.g. tissue, organisms
    • G01N33/5088Supracellular entities, e.g. tissue, organisms of vertebrates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/10Musculoskeletal or connective tissue disorders
    • G01N2800/105Osteoarthritis, e.g. cartilage alteration, hypertrophy of bone
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK16898834.3T 2016-04-15 2016-04-15 Fremgangsmåde til evaluering af artikulære ledterapi DK3442657T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2016/027789 WO2017180150A1 (en) 2016-04-15 2016-04-15 Method for evaluating articular joint therapeutics

Publications (1)

Publication Number Publication Date
DK3442657T3 true DK3442657T3 (da) 2022-10-03

Family

ID=60042860

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16898834.3T DK3442657T3 (da) 2016-04-15 2016-04-15 Fremgangsmåde til evaluering af artikulære ledterapi

Country Status (14)

Country Link
EP (1) EP3442657B1 (da)
JP (1) JP6768922B2 (da)
AU (1) AU2016402361B2 (da)
BR (1) BR112018071091A2 (da)
CA (1) CA3020688C (da)
DK (1) DK3442657T3 (da)
ES (1) ES2928171T3 (da)
HU (1) HUE060598T2 (da)
PL (1) PL3442657T3 (da)
PT (1) PT3442657T (da)
RS (1) RS63770B1 (da)
RU (1) RU2714312C1 (da)
SI (1) SI3442657T1 (da)
WO (1) WO2017180150A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2953017T3 (es) * 2018-04-03 2023-11-07 Sanofi Sa Dispositivo de tira de inmunoensayo de flujo lateral
JP7421744B2 (ja) * 2019-08-28 2024-01-25 学校法人順天堂 変形性関節症の診断
KR102288646B1 (ko) * 2020-01-30 2021-08-11 충남대학교산학협력단 반려동물 골관절염 진단용 당사슬 바이오마커 및 이를 이용한 반려동물 골관절염 진단방법
KR102384149B1 (ko) * 2020-09-09 2022-04-08 아주대학교산학협력단 턱관절 골관절염 진단 또는 예후 예측용 바이오마커 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050221383A1 (en) * 2003-08-08 2005-10-06 Choong-Chin Liew Osteoarthritis biomarkers and uses thereof
US20050124071A1 (en) 2003-09-30 2005-06-09 Kraus Virginia B. Methods and compositions for diagnosing musculoskeletal, arthritic and joint disorders by biomarker dating
WO2005036446A2 (en) * 2003-10-07 2005-04-21 Entelos, Inc. Simulating patient-specific outcomes
WO2007089303A2 (en) * 2005-11-01 2007-08-09 Abbott Biotechnology Ltd. Methods and compositions for diagnosing ankylosing spondylitis using biomarkers
US20090299769A1 (en) * 2008-05-29 2009-12-03 Nordic Bioscience Imaging A/S Prognostic osteoarthritis biomarkers
CA2790684C (en) * 2010-02-22 2019-02-12 Duke University Biomarkers of musculoskeletal disease
US8428045B2 (en) * 2010-03-16 2013-04-23 Harman International Industries, Incorporated Media clock recovery

Also Published As

Publication number Publication date
AU2016402361A1 (en) 2018-11-01
JP6768922B2 (ja) 2020-10-14
RU2714312C1 (ru) 2020-02-14
CA3020688A1 (en) 2017-10-19
RS63770B1 (sr) 2022-12-30
CA3020688C (en) 2022-07-12
AU2016402361B2 (en) 2022-08-11
EP3442657B1 (en) 2022-07-27
EP3442657A1 (en) 2019-02-20
JP2019517007A (ja) 2019-06-20
BR112018071091A2 (pt) 2019-01-29
ES2928171T3 (es) 2022-11-15
PT3442657T (pt) 2022-10-13
SI3442657T1 (sl) 2023-01-31
WO2017180150A1 (en) 2017-10-19
EP3442657A4 (en) 2019-10-16
HUE060598T2 (hu) 2023-03-28
PL3442657T3 (pl) 2023-01-23

Similar Documents

Publication Publication Date Title
DK3331915T3 (da) Immun-checkpoint-inhibitorer til anvendelse til behandling af blodbårne cancere
DK3286181T3 (da) Pyrazolforbindelser og fremgangsmåde til fremstilling og anvendelse af forbindelserne
DK3192902T3 (da) Fremgangsmåde til fremstilling af graphenholdige viscosefibre
DK3189082T3 (da) Anti-pd-l1-konjugater til behandling af tumorer
DK3096741T3 (da) Fremgangsmåde til fremstillingen af hybridosomer
DK3160956T3 (da) Inhibitorer af lysin-specifik demethylase-1
DK3143025T3 (da) Forbindelser til behandling af spinal muskelatrofi
DK3294720T3 (da) Fremgangsmåde til fremstilling af terpinolenepoxid
DK3174858T3 (da) Fremgangsmåde til fremstilling af pyrazoler
DK3511319T3 (da) Hæmmere af lysinspecifik demethylase-1
DK3668851T3 (da) Fremgangsmåde til fremstilling af thiocarbonater
DK3325443T3 (da) Fremgangsmåde til fremstilling af pridopidin
DK3317400T3 (da) Fremgangsmåde til kryokonservering af tumorinfiltrerende lymfocytter
DK3240612T3 (da) Fremgangsmåder til behandling af nethindesygdomme
DK3362066T3 (da) Kombinationsterapi til behandling af maligniteter
DK3390390T3 (da) Bipyrazolylderivater egnede til behandling af autoimmunsygdomme
DK3331879T3 (da) Benzazolforbindelser og fremgangsmåder til fremstilling og anvendelse af forbindelserne
DK3166628T3 (da) Terapeutisk anvendelse af knoglemorfogenetiske proteiner
DK3280408T3 (da) Fremgangsmåde til fremstilling af dicycloplatin
DK3363148T3 (da) Afdækning af krypteringsanvendelse
FI20155191A (fi) Nivel
DK3347342T3 (da) Fremgangsmåde til fremstilling af biguanidin-salte og s-triaziner
DK3297619T3 (da) Terapeutiske anvendelser af L-4-chlorkynurenin
DK3286317T3 (da) Dynamin 2-inhibitor til behandlingen af duchennes muskeldystrofi
DK3488443T3 (da) Udvælgelse af neoepitoper som sygdomsspecifikke mål for terapi med øget virkning